Barzilai N, Shuldiner AR. Searching for human longevity genes: the future history of gerontology in the post-genomic era. J Gerontol 2001; 56A: M83-M87.

Bean P. Update on HIV patient management: latest trends in laboratory testing immune cell reconstitution, and vaccine development. Am Clin Lab 2001; 20: 7-8.

Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JL, Isaacs WB, Jensen RH. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 1996; 56: 3091-3102.

Collins FS, Patrinos A, Jordan E, Chakravati A, Gesteland R, Walters L. New goals for the US Human Genome Project 1998-2003. Science 1998; 282: 682-9.

Davidson MJ, Jones JM, Emani SM, Wilson KH, Jaggers J, Koch WJ, Milano CA. Cardiac gene delivery with cardiopulmonary bypass. Circulation 2001; 10: 131-3.

Gray JW, Collins C. Genome changes and gene expression in human solid tumors. Carcinogenesis 21; 443-52.

Han E, Hilsenbeck SG. Array-based gene expression profiling to study aging. Mech Ageing Dev 2001; 122: 999-1018.

Hingten SD, Davisson RL. Gene therapeutic approaches to oxidative stress-induced cardiac disease: principles, progress and prospects. Antiox Redox Signal 2001; 3: 433-49.

Jazwinski SM. Coordination of metabolic activity and stress resistance in yeast longevity. Results Probl Cell Differ 2000; 29: 21-44.

Jazwinski SM. Metabolic control and gene dysregulation in yeast aging. Ann N Y Acad Sci 2000; 908: 21-30.

Jiminez-Sanchez G, Childs B, Valle D. Human disease genes. Nature 2001; 409: 853-5.

Kallioniemi A, Kallioniemi OP, Piper J, Tanner M, Stokke T, Chen L, Smith HS, Pinkel D, Grey JW, Waldman FM. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci USA 1994; 91: 2156-60.

Lathi KG, Vale PR, Losordo DW, Cespedes RM, Symes JF, Esakof DD, Maysky M, Isner JM. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: anesthetic management and results. Anesth Analg 2001; 92: 19-25.

Link CD. Transgenic invertebrate models of age-associated neurodegenerative diseases. Mech Ageing Dev 2001; 122: 1629-49.

Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 2000; 405: 827-836.

McLeod HL, Evans WE. Pharmacogenomics: unlocking the human genome for better drug therapy. Annu Rev Pharmacol Toxicol 2001; 41: 101-21.

Montgomery L, Tuberculosis vaccine design: influence of the completed genome sequence. Brief Bioinform 2000; 1: 289-296.

Nass R, Miller DM, Blakely RD. C. elegans: a novel pharmacogenetic model to study Parkinson's disease. Parkinsonism Relat Disord 2001; 7: 185-91.

O'Connell P, Pekkel V, Fuqua SA, Osborne CK, Clark GM, Allred DC. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Nat Cancer Inst 1998; 90: 697-703.

Read TD, Gill SR, Tettelin H, Dougherty BA. Finding drug targets in microbial genomes. Drug Discov Today 2001; 6: 887-92.

Rew DA. The drosophila genome and its oncological implications. Eur J Surg Oncol 2001; 27: 105-8.

Sellers KW, Katovich MJ, Gelband CH, Raizada MK. Gene therapy to control hypertension: current studies and future perspectives. Am J Med 2001; 322: 1-6.

Sreekumar KR, Aravind L, Koonin EV. Computational analysis of human disease-associated genes and their protein products. Curr Opin Genet Dev 2001; 11: 247-57.

Vajo Z, King LM, Jonassen T, Wilkin DJ, Ho N, Munnich A, Clarke CF, Francomano CA. Conservation of the Caenorhabditis elegans timing gene clk-1 from yeast to human: a gene required for ubiquinone synthesis with potential implications for aging. Mamm Genome 1999; 10: 1000-4.